PoroUS
Amsterdam
About PoroUS
PoroUS combines non-ionizing 3D ultrasound technology and image guidance with sophisticated spectral signal processing to ensure the osteoporosis diagnosis. PoroUS’ cortical ultrasound back-scatter analysis offers a novel way to detect microstructural changes (porosity and thickness) in the cortical bone. PoroUS provides a precision- and operating independence-tool, which will improve the cost effectiveness and reduce the economic burden by preventing fragility fractures.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 251 – 500
- Total funding: $2.6M
- Funding stage: Seed
- Last round: Seed (Jun 2022)
- Website: nlc.healthventureporous
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical, Medical Device
Canonical: https://fsome.com/organization/porous-130598 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.